Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Zollinger-Ellison Syndrome 1Tongue Neoplasms 1Stomatitis 1Somatostatinoma 1Radiation Injuries 1Paraganglioma 1Insulinoma 1Head and Neck Neoplasms 1Glucagonoma 1Gliosarcoma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1

Interventions

Cetuximab 2sargramostim 1Salts 1Ritonavir 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Moxibustion 1Molecular Diagnostic Techniques 1Indinavir 1Immunotherapy 1Gefitinib 1Fluorodeoxyglucose F18 1FPP(RGD)2 1Everolimus 1Erlotinib Hydrochloride 1Drug Therapy 1Doxepin 1Diffusion Tensor Imaging 1Cyclophosphamide 1Cryosurgery 1Biological Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tongue Neoplasms × Salts × CNS × Clear all
NCT00293462 2021-07-30

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

University of California, San Francisco

Phase 3 Completed
91 enrolled 16 charts
CNSHead & Neck

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡